Latest On CollPlant Biotechnologies Ltd (CLGN):
About CollPlant Biotechnologies Ltd (CLGN):
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bio-printing of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants; VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
General
- Name CollPlant Biotechnologies Ltd
- Symbol CLGN
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 38
- Last Split Factor2:3
- Last Split Date2016-11-21
- Fiscal Year EndDecember
- IPO Date2018-01-30
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Web URLhttp://www.collplant.com
Valuation
- Forward PE 10.06
- Price/Sales (Trailing 12 Mt.) 15.66
- Price/Book (Most Recent Quarter) 19.19
- Enterprise Value Revenue 21.63
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate $0.23
- Profit Margin -122%
- Operating Margin -91%
- Return on Assets -27%
- Return on Equity -268%
- Revenue 6.02 million
- Earnings Per Share -$0.82
- Revenue Per Share $0.91
- Gross Profit 439000
- Quarterly Earnings Growth 510.9%
Highlights
- Market Capitalization 123.73 million
- EBITDA -3208455
- Analyst Target Price $23
- Book Value Per Share $1.05
Share Statistics
- Shares Outstanding 9.29 million
- Shares Float 4.11 million
- % Held by Insiders 3481%
- % Held by Institutions 13.55%
- Shares Short 3188
- Shares Short Prior Month 2980
- Short Ratio 0.01
Technicals
- Beta 0.63
- 52 Week High $24.26
- 52 Week Low $6.19
- 50 Day Moving Average 16.47
- 200 Day Moving Average 10.97
Dividends
- Dividend Date 2016-11-21
- ExDividend Date N/A
- Dividend Yield 0%
CollPlant Biotechnologies Ltd (CLGN) Dividend Calendar:
CLGN's last dividend payment was made to shareholders on November 21, 2016.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
CollPlant Biotechnologies Ltd (CLGN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-12-01 | $N/A | $0.11 | $1.90 | -94.21% |
2020-06-30 | 2020-08-28 | $N/A | -$0.28 | -$0.25 | -12.79% |
2020-03-31 | 2020-04-01 | $609000 | -$0.77 | -$0.13 | -490.91% |
2019-12-31 | 2019-12-31 | $439000 | -$0.25 | -$0.25 | 0% |
2019-09-30 | 2019-11-29 | $679000 | -$0.69 | -$0.26 | -164.4% |
2019-06-30 | 2019-09-26 | $606000 | -$0.33 | ||
2019-03-31 | 2019-04-01 | $594000 | $0.01 | $0.01 | -48.11% |
2018-12-31 | 2019-03-31 | $15.79 million | -$0.29 | ||
2018-09-30 | 2018-11-29 | $813000 | -$0.01 | ||
2018-06-30 | 2018-09-21 | $653000 | -$0.36 | ||
2018-03-31 | 2018-05-24 | $220880.12 | -$0.61 | ||
2017-12-31 | 2018-03-21 | $442926.72 | -$0.51 | ||
2017-09-30 | 2017-09-30 | $68000 | -$0.01 | ||
2017-06-30 | 2017-06-30 | $6000 | -$0.01 | ||
2017-03-31 | 2017-03-31 | $69000 | -$0.01 | ||
2016-12-31 | 2016-12-31 | -$0.02 | |||
2016-09-30 | 2016-09-30 | -$0.05 | |||
2016-06-30 | 2016-06-30 | -$0.02 | |||
2016-03-31 | 2016-03-31 | -$0.02 | |||
2015-12-31 | 2015-12-31 | -$0.01 | |||
2015-09-30 | 2015-09-30 | -$0.01 | |||
2015-06-30 | 2015-06-30 | -$0.01 |
CollPlant Biotechnologies Ltd (CLGN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
CollPlant Biotechnologies Ltd (CLGN) Chart:
CollPlant Biotechnologies Ltd (CLGN) News:
Below you will find a list of latest news for CollPlant Biotechnologies Ltd (CLGN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
CollPlant Biotechnologies Ltd (CLGN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-04-19 | 2.5 | 0 | CALL | 0 | 0 | 315.81 | TRUE | 0 | 0 |
2024-04-19 | 5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
2024-04-19 | 7.5 | 0.18 | CALL | 1 | 8 | 0 | FALSE | 0 | 0 |
2024-04-19 | 10 | 0.45 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-04-19 | 12.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-04-19 | 5 | 0.6 | PUT | 8 | 20 | 0 | FALSE | 0 | 0 |
2024-04-19 | 7.5 | 1.65 | PUT | 0 | 1 | 175.27 | TRUE | 0 | 0 |
2024-04-19 | 10 | 4.4 | PUT | 1 | 1 | 200.1 | TRUE | 0 | 0 |
2024-04-19 | 12.5 | 0 | PUT | 0 | 0 | 241.62 | TRUE | 0 | 0 |
2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 271.34 | TRUE | 0 | 0 |
2024-05-17 | 5 | 0 | CALL | 0 | 0 | 80.94 | TRUE | 0 | 0 |
2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 5 | 0 | PUT | 0 | 0 | 90.21 | FALSE | 0 | 0 |
2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 163.61 | TRUE | 0 | 0 |
2024-05-17 | 10 | 0 | PUT | 0 | 0 | 103.71 | TRUE | 0 | 0 |
2024-07-19 | 2.5 | 2.98 | CALL | 0 | 1 | 171.88 | TRUE | 0 | 0 |
2024-07-19 | 5 | 0 | CALL | 0 | 0 | 65.03 | TRUE | 0 | 0 |
2024-07-19 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-07-19 | 5 | 0.6 | PUT | 3 | 2 | 64.21 | FALSE | 0 | 0 |
2024-07-19 | 7.5 | 0 | PUT | 0 | 0 | 75.93 | TRUE | 0 | 0 |
2024-07-19 | 10 | 0 | PUT | 0 | 0 | 181.51 | TRUE | 0 | 0 |
2024-10-18 | 2.5 | 0 | CALL | 0 | 0 | 307.6 | TRUE | 0 | 0 |
2024-10-18 | 5 | 0 | CALL | 0 | 0 | 74.19 | TRUE | 0 | 0 |
2024-10-18 | 7.5 | 0.5 | CALL | 0 | 1 | 55.71 | FALSE | 0 | 0 |
2024-10-18 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-10-18 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-10-18 | 5 | 0 | PUT | 0 | 0 | 72.3 | FALSE | 0 | 0 |
2024-10-18 | 7.5 | 0 | PUT | 0 | 0 | 73.49 | TRUE | 0 | 0 |
2024-10-18 | 10 | 0 | PUT | 0 | 0 | 115.85 | TRUE | 0 | 0 |
Latest CLGN Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 5:20 PM EST | 100 | $8.17 |
Jun 13, 2022 1:30 PM EST | 100 | $8.5 |
Jun 13, 2022 7:17 PM EST | 100 | $8.03 |
Jun 13, 2022 7:17 PM EST | 44 | $8.02 |
CollPlant Biotechnologies Ltd (CLGN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-05 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1631487/999999999520001359/9999999995-20-001359-index.htm |
2020-06-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1631487/000000000020004971/0000000000-20-004971-index.htm |
2019-09-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631487/000110465919050200/0001104659-19-050200-index.htm |
2019-09-18 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631487/000110465919050575/0001104659-19-050575-index.htm |
2019-09-18 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631487/000110465919050576/0001104659-19-050576-index.htm |
2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631487/000117891320000365/0001178913-20-000365-index.htm |
2019-06-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019010152/0001213900-19-010152-index.htm |
2019-06-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019011089/0001213900-19-011089-index.htm |
2019-06-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1631487/000121390019011109/0001213900-19-011109-index.htm |
2019-07-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019012530/0001213900-19-012530-index.htm |
2019-08-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019014555/0001213900-19-014555-index.htm |
2019-08-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019014966/0001213900-19-014966-index.htm |
2019-08-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1631487/000121390019015250/0001213900-19-015250-index.htm |
2019-08-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019016224/0001213900-19-016224-index.htm |
2019-08-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019016598/0001213900-19-016598-index.htm |
2019-08-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019017036/0001213900-19-017036-index.htm |
2019-09-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019017097/0001213900-19-017097-index.htm |
2019-09-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019017456/0001213900-19-017456-index.htm |
2019-09-10 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1631487/000121390019017636/0001213900-19-017636-index.htm |
2019-09-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019018141/0001213900-19-018141-index.htm |
2019-09-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019018950/0001213900-19-018950-index.htm |
2019-10-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019021662/0001213900-19-021662-index.htm |
2019-11-05 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1631487/000121390019022022/0001213900-19-022022-index.htm |
2019-11-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019024491/0001213900-19-024491-index.htm |
2019-11-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019025016/0001213900-19-025016-index.htm |
2019-12-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019026517/0001213900-19-026517-index.htm |
2019-12-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390019027307/0001213900-19-027307-index.htm |
2020-01-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020000209/0001213900-20-000209-index.htm |
2020-01-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020000851/0001213900-20-000851-index.htm |
2020-02-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020002466/0001213900-20-002466-index.htm |
2020-02-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020003025/0001213900-20-003025-index.htm |
2020-02-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020003745/0001213900-20-003745-index.htm |
2020-03-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020005629/0001213900-20-005629-index.htm |
2020-03-09 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1631487/000121390020005755/0001213900-20-005755-index.htm |
2020-04-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020008283/0001213900-20-008283-index.htm |
2020-04-01 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020008285/0001213900-20-008285-index.htm |
2020-04-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020008771/0001213900-20-008771-index.htm |
2020-05-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020012294/0001213900-20-012294-index.htm |
2020-05-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020013493/0001213900-20-013493-index.htm |
2020-05-27 | F-3 | Registration statement by foreign private issuers | https://www.sec.gov/Archives/edgar/data/1631487/000121390020013527/0001213900-20-013527-index.htm |
2020-06-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1631487/000121390020014083/0001213900-20-014083-index.htm |
2020-06-05 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020014237/0001213900-20-014237-index.htm |
2020-08-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020024100/0001213900-20-024100-index.htm |
2020-08-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1631487/000121390020024251/0001213900-20-024251-index.htm |
2020-09-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020024801/0001213900-20-024801-index.htm |
2020-09-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020026346/0001213900-20-026346-index.htm |
2020-09-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020027440/0001213900-20-027440-index.htm |
2020-10-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020030964/0001213900-20-030964-index.htm |
2020-10-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1631487/000121390020033141/0001213900-20-033141-index.htm |
2020-06-05 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1631487/999999999520001359/9999999995-20-001359-index.htm |